Anatomic Pathology Market Size was valued at USD 40.28 Billion in 2023. The Anatomic Pathology industry is projected to grow from USD 43.14 Billion in 2024 to USD 74.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.15% during the forecast period (2024 - 2032). It has been seen that the world market is growing steadily in the forecast period. Anatomical pathology is also defined as a medical specialty or the commonwealth, which is concerned with diagnosing disease in terms of the microscopic, macroscopic, immunologic, biochemical, and molecular examination of tissues and organs. Anatomic pathology usually requires a physician who is trained in pathological diagnosis to do the processing, diagnosis, and examination of surgical examples.
In 2020, the services for anatomical pathology were accounted to hold the largest market share due to the growing incidence of cancer and other chronic diseases, continuous growth in the geriatric population, and reimbursements availability for diagnostic tests across the world.
As per the anatomic pathology market outlook report, the current market consists of different intended audiences such as consumable manufacturers & suppliers, anatomic pathology instrument manufacturers & suppliers, research and development (R&D) companies, pathology service providers, government and independent regulatory authorities, contract research organizations (CROs), academic institutes and universities, government research laboratories, consulting and market research service providers, and independent research laboratories.
COVID-19 Analysis
Every aspect of the diagnostics industry has been impacted due to the coronavirus outbreak across the world. The Covid-19 pandemic had a profound impact on the patients who are going through treatment, diagnosis, and cancer screening. At this time, many diagnostic and treatment procedures got postponed or canceled across the globe, which has affected the global market.
Moreover, the lockdown-related restrictions have delayed treatment and diagnosis of cancer patients, which has increased cancer mortality rates across the world. However, the anatomic pathology market players have worked harder to enhance the market growth during the forecast period.
According to the World Health Organisation (WHO), cancer disease is the second-leading cause of death across the world, and nearly 19.3 million new cancer cases and 10 million deaths cases were accounted for in 2020 due to cancer. This is further projected to increase to 30.2 million by the end of the year 2040. Hence, the rising cases of cancer and other target diseases among the population are increasing the market demand for anatomic pathology in the research period.
Moreover, the increasing support of the government to develop and innovate new advanced things for anatomic pathology is driving the market size during the research timeframe.
The worldwide anatomic pathology market growth might experience challenges due to the availability of refurbished anatomic pathology instruments across the world. The refurbished anatomic pathology instruments like microtomes, staining systems, and tissue processors are provided by some of the prominent market players such as Rankin Biomedical Corporation (US), LabX (US), Swerdlick Medical Systems (US), and AL-TAR (US).
Moreover, the high cost associated with anatomic pathology might be one of the major challenges for the market of anatomic pathology during the assessment timeframe.
In oncology drug trials, the anatomic pathology products and services are extensively used to detect morphological structures, analyze quantitative information, understand drug mechanisms and detect pharmacodynamic markers. Hence, the rising number of clinical trials pertaining to cancer drugs and any other drugs are estimated to bring lucrative market opportunities for the anatomic pathology.
Apart from this, the manufacturers and market players have more significant opportunities due to the rising investment, product innovation and ongoing R&D activities in the market for anatomic pathology.
The market of anatomic pathology might get affected due to the lack of professionals and physicians for anatomic pathology.
Also, the high cost associated with anatomic pathology might hamper the growth of the market during the forecast period.
Cumulative Evaluation of The Market
As per the market trends report, significant growth has been seen in recent years and is expected to grow steadily in the upcoming years.
Furthermore, the market value is effectively extending due to the continuous efforts of the key players. They are adopting new strategies and collaboration to maintain the market share in the further coming years.
The market of anatomic pathology is classified based on application, end-users and type.
In terms of the application segment, the market has been divided into medical research and development and disease diagnostics for diseases like lymphoma, cancer, and others.
Among these, the disease diagnostics segment is registered to account for the largest market share anatomic pathology during the year 2020. This segment is expanding due to the rising incidence of cancer and other chronic diseases and rapid growth in the geriatric population.
On the basis of type segment, the market of anatomic pathology has been segregated into consumables, instruments, and services.
Here, the instrument type segment includes Slide Staining Systems, Cell Processors, Tissue Processing Systems, Coverslippers, Embedding Systems, Microtomes, and other instruments. Further, the consumable type segment is sub-segregated into antibodies (primary and secondary antibodies), probes, kits &reagents (fixatives, stains &solvents, and other kits &reagents) and other consumables. Moreover, the services segment is further divided into cytopathology and histopathology.
Depending on the end-user segment, the market of anatomic pathology has been classified into physician office laboratories, clinical office laboratories, hospitals, and others.
In 2020, the hospital laboratories were registered to account for the largest anatomic pathology market share because of the rising awareness about early disease diagnosis, the growing number of patient visits to hospitals, and the increasing in-house diagnostic procedures performed in hospitals. Moreover, the availability of reimbursements for clinical tests in hospitals is projected to fuel the global market.
Globally, the market of anatomic pathology has been divided into different geographical areas such as Asia Pacific, North America, Europe, and the rest of the world.
The North American anatomic pathology market is projected to generate the largest market share for anatomic pathology during the research period due to the rising healthcare expenditure and increasing prevalence of chronicle diseases in the region. Moreover, the presence of major key players in the North American region is fuelling the global market growth during the review timeframe. Also, the increasing high-quality infrastructure for clinical laboratories and hospitals is driving the market growth in North America.
Among these, the European anatomic pathology market is projected to be the second-largest market for anatomic pathology during the assessment period. This region is expanding due to the government initiatives for screening cancer patients and easy accessibility to new and advanced technology in the region. Further, the Asia pacific regional market is anticipated to be the fastest-growing market during the research timeframe.
Competitive Intensity Within the Industry
According to the anatomic pathology market analysis, the prominent market players are working efficiently to compete with the other competitors to show their presence to the world. In this analysis report, the prominent key players profiled are:
The covered companies are playing an important role in the anatomic pathology market growth by giving their continuous support in innovating things. These players are focusing more on the research and developmental activities related to anatomic pathology.
Recent Market Developments
Report Overview
Presently, the global market has shown significant growth. Based on the anatomic pathology market forecast report, the global market has been segmented into applications, types and end-users. This report has also highlighted the market overview, market segmentation, regional classification, competitive landscape, recent development, and covid-19 analysis to get insight into the global market.
Moreover, this report is a combination of both qualitative and quantitative analysis that gives a better understanding of the market for anatomic pathology.
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 74.81 Billion |
| Â Â CAGR | Â 7.15% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2021 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Type, Application and End Users |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, Abcam, AdnaGen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Biocare Medical, Biocartis, CellMax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, RareCyte, SAKURA FINETEK USA, Tecan, and VolitionRx |
| Â Â Key Market Opportunities | Â Â Joint ventures, strategic alliances, mergers and acquisitions |
| Â Â Key Market Drivers | Â Â Increasing numbers of laboratory and pathological services |
Anatomic Pathology Market Highlights:
Frequently Asked Questions (FAQ) :
The valuation of the global anatomic pathology market is estimated to increase to USD 74.80 Billion by the end of 2032.
Increasing numbers of laboratory and pathological services, benefits extended by anatomic pathology in understanding the effect of diseases, developments in postmortem procedures, and augmenting demand for AP and molecular oncology services in healthcare are major drivers of the global anatomic pathology market.
North America holds the largest share in the global anatomic pathology market, followed by Europe and the Asia Pacific, respectively.
Oxford Cancer Biomarkers, Agilent Technologies, Abbott Diagnostics, Roche Diagnostics, Danaher, Abcam, Advanced Cell Diagnostics, Janssen Diagnostic, Agendia, SAKURA FINETEK USA, Thermo Fisher Scientific, Tecan, AutoGenomics, Angsana Molecular & Diagnostics Laboratory, Monogram Biosciences, Nucleix, Biocartis, CellMax Life, AdnaGen, Biocare Medical, Cancer Genetics, Enzo Biochem, Digipath, Epic Sciences, RareCyte, Omnyx, and VolitionRx., are some of the major players operating in the anatomic pathology market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global anatomic pathology market adopt to gain a larger competitive advantage.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
